which glp is retatrutide Subcutaneous Fat Loss Results: What Clinical Trials Reveal About Effectiveness and Safety Retatrutide Triple Agonist (GLP-1/GIP/GCG) |

Convenient Administration : Available in easy-to-use injection forms

MOTS-c is an unregulated research compound, FDA-ineligible for compounding, and prohibited by WADA under S4.4.1 (AMPK activators)

Men and women had equal obesity prevalence rates overall, but women were more likely to have severe obesity than men

While GLP-1 treatments have been approved by the FDA for weight management, and not just for diabetics, there are still some hurdles people have to overcome, like meeting certain BMI requirements, finding a licensed provider, or covering expensive out-of-pocket costs for the treatment if their insurance provider doesn't cover weight loss treatments